These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9701231)

  • 1. Lessons from an age-old war.
    Powis SH
    Nat Med; 1998 Aug; 4(8):887-8. PubMed ID: 9701231
    [No Abstract]   [Full Text] [Related]  

  • 2. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.
    Chen Z; Hagler J; Palombella VJ; Melandri F; Scherer D; Ballard D; Maniatis T
    Genes Dev; 1995 Jul; 9(13):1586-97. PubMed ID: 7628694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.
    Palombella VJ; Rando OJ; Goldberg AL; Maniatis T
    Cell; 1994 Sep; 78(5):773-85. PubMed ID: 8087845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.
    Alkalay I; Yaron A; Hatzubai A; Orian A; Ciechanover A; Ben-Neriah Y
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10599-603. PubMed ID: 7479848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide.
    Gao Y; Lecker S; Post MJ; Hietaranta AJ; Li J; Volk R; Li M; Sato K; Saluja AK; Steer ML; Goldberg AL; Simons M
    J Clin Invest; 2000 Aug; 106(3):439-48. PubMed ID: 10930447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A minimal glycine-alanine repeat prevents the interaction of ubiquitinated I kappaB alpha with the proteasome: a new mechanism for selective inhibition of proteolysis.
    Sharipo A; Imreh M; Leonchiks A; Imreh S; Masucci MG
    Nat Med; 1998 Aug; 4(8):939-44. PubMed ID: 9701247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteasome regulation of Fas ligand cytotoxicity.
    Matsui K; Omura S; Cui H; Schauer SL; Sonenshein GE; Ju ST
    Eur J Immunol; 1997 Sep; 27(9):2269-78. PubMed ID: 9341769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.
    Levitskaya J; Sharipo A; Leonchiks A; Ciechanover A; Masucci MG
    Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12616-21. PubMed ID: 9356498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of NF-kappa B inhibitor I kappa B alpha: ubiquitin-dependent proteolysis and its degradation product.
    Li CC; Dai RM; Longo DL
    Biochem Biophys Res Commun; 1995 Oct; 215(1):292-301. PubMed ID: 7575604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the ubiquitin proteolytic system in murine acquired immunodeficiency syndrome affects IkappaBalpha turnover.
    Crinelli R; Bianchi M; Gentilini L; Magnani M; Hiscott J
    Eur J Biochem; 1999 Jul; 263(1):202-11. PubMed ID: 10429205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation.
    Desterro JM; Rodriguez MS; Hay RT
    Mol Cell; 1998 Aug; 2(2):233-9. PubMed ID: 9734360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The carboxy-terminus of I kappaB alpha determines susceptibility to degradation by the catalytic core of the proteasome.
    Kroll M; Conconi M; Desterro MJ; Marin A; Thomas D; Friguet B; Hay RT; Virelizier JL; Arenzana-Seisdedos F; Rodriguez MS
    Oncogene; 1997 Oct; 15(15):1841-50. PubMed ID: 9362451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo.
    Krappmann D; Wulczyn FG; Scheidereit C
    EMBO J; 1996 Dec; 15(23):6716-26. PubMed ID: 8978697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel in vitro assay for deubiquitination of I kappa B alpha.
    Strayhorn WD; Wadzinski BE
    Arch Biochem Biophys; 2002 Apr; 400(1):76-84. PubMed ID: 11913973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of NF-kappa B in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells.
    Franco AV; Zhang XD; Van Berkel E; Sanders JE; Zhang XY; Thomas WD; Nguyen T; Hersey P
    J Immunol; 2001 May; 166(9):5337-45. PubMed ID: 11313369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of proteasome inhibitors on monocytic IkappaB-alpha and -beta depletion, NF-kappaB activation, and cytokine production.
    Haas M; Page S; Page M; Neumann FJ; Marx N; Adam M; Ziegler-Heitbrock HW; Neumeier D; Brand K
    J Leukoc Biol; 1998 Mar; 63(3):395-404. PubMed ID: 9500529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen processing. Peptides and the proteasome.
    Howard JC; Seelig A
    Nature; 1993 Sep; 365(6443):211-2. PubMed ID: 8371776
    [No Abstract]   [Full Text] [Related]  

  • 19. Survival of the fitters.
    Rammensee HG
    Nature; 2002 Oct; 419(6906):443-5. PubMed ID: 12368840
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunology. Hide and seek in the peptidome.
    Yewdell JW
    Science; 2003 Sep; 301(5638):1334-5. PubMed ID: 12958347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.